Clinical Trials on Partial Edentulism Class 1 in Italy

Total 7 results

University of Catania

Completed

Impact of Cantilever Design on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study

Partial Edentulism

Italy
D'Albis Dental

Completed

Implant-supported Zirconia Partial Dentures With Cantilever

Partial-edentulism

Italy
ZimVie

Completed

Prospective Study of NanoTite Implants Placed Into Fresh Sinus-Lift Augmentation Sites (VSSL)

Partial Edentulism | Tooth Disease

Italy
Dentsply Sirona Implants

Completed

Multicenter Study Comparing OsseoSpeed TX With OsseoSpeed EV.

Partial Edentulism in the Maxilla or in the Mandible

United States, Belgium, Germany, Italy
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
UCB Biopharma SRL

Terminated

A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis

Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis

United States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
Hoffmann-La Roche
Chugai Pharmaceutical Co.

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo)

NMDAR Autoimmune Encephalitis | LGI1 Autoimmune Encephalitis

United States, Korea, Republic of, China, Japan, Czechia, Italy, Poland, Austria, Brazil, Argentina, Netherlands, Taiwan, France, Denmark, Ghana

Clinical Trials on Partial Edentulism Class 1 in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations